When faced with a threat, T cells have the decision-making flexibility to both clear out the pathogen now and ready themselves for a future encounter.
Articles on Cytotoxic T cells
Displaying all articles
T cells recognize and kill cancer cells but quickly lose their effectiveness. This fast dysfunction may help explain why immunotherapy doesn’t lead to long-term remission for many patients.
Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.
While a strong immune response is essential to fight against viral infection, an immune system that continues to stay active long after the virus has been cleared can lead to lung damage.
To get an effective vaccine for HIV/AIDS, scientists need to understand exactly how the virus works and immune system responds to it. African scientists have come one step closer.
Top contributors
-
Assistant Professor of Medicine and Pathology, Vanderbilt University
-
Assistant Professor of Medicine, University of California, San Francisco
-
Ph.D. Candidate in Bioengineering, University of Washington
-
MD-Ph.D. Candidate in Molecular Pathology and Immunology, Vanderbilt University
-
Ph.D. Candidate in Immunology, University of Virginia
-
Associate Professor of Bioengineering, University of Washington
-
Ph.D. Candidate in Bioengineering, University of Washington
-
Director for basic and translational science, Africa Health Research Institute (AHRI)